ARTICLE | Clinical News
Oral antibacterial agent: IG's Novavax division will begin a Phase I trial in the fourth quarter
September 18, 1995 7:00 AM UTC
IGI Inc. (IG), Buena, N.J. Product: Oral antibacterial agent Indication: Helicobacter pylori infection Status: IG's Novavax division will begin a Phase I trial in the fourth quarter ...